// App-Quantinova.ai

SAT0243 : SUBPHENOTYPES IN POLYARTERITIS NODOSA (PAN): TARGET ORGAN ASSOCIATIONS OF A WORLDWIDE COLLABORATION STUDY

Researchers

Presenter

  • O. Karadag

Principal Investigators

  • S. Furuta

  • G. Emmi

  • A. Hocevar

  • A. Hinojosa-Azaola

  • A. J. Mohammad

  • S. Ugurlu

  • F. Alibaz-Oner

  • A. Yazici

  • L. Quartuccio

  • E. Bozzolo

  • L. Dagna

  • G. A. Ramirez

  • L. Cantarini

  • G. Gregorini

  • J. Guido

  • S. Monti

  • E. Martin-Nares

  • F. Schiavon

  • R. Padoan

  • H. Kono

  • A. Vaglio

  • S. Kilikap

  • A. I. Ertenli

  • H. Direskeneli

  • S. zen

  • D. Jayne

Medical Centers

  • Hacettepe University Vasculitis Center HUVAC, Ankara, Turkey

  • Vasculitis and Lupus Clinic, Addenbrookes Hospital University of Cambridge, Cambridge, United Kingdom

  • Chiba University Hospital, Chiba, Japan

  • Universita di Firenze, Florence, Italy

  • University Medical Centre Ljubljana, Ljubljana, Slovenia

  • Instituto Nacional de Ciencias, Ciudad de México, Mexico

  • Lund University Hospital, Lund, Sweden

  • Cerrahpasa Tip Fakultesi, Istanbul, Turkey

  • Marmara University, Medical Oncology, Istanbul, Turkey

  • Kocaeli Üniversitesi Tip Fakültesi, Rheumatology, Kocaeli, Turkey

  • Academic Hospital “Santa Maria della Misericordia, Udine, Italy

  • San Raffaele Hospital, Milan, Italy

  • Cardiology, University of Siena, Siena, Italy

  • University of Brescia, Brescia, Italy

  • Rheumatology, IRCCS Fondazione Policlinico S. Matteo, Monti, Turkey

  • Unit of Rheumatology, University of Padova, Padova, Italy

  • Teikyo University, Tokyo, Japan

Locations

  • Turkey

  • United Kingdom

  • Japan

  • Italy

  • Slovenia

  • Mexico

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Polyarteritis nodosa

Biomarkers

  • Cancer antigen 15-3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved